Evolv Technologies (IMBI) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

IMBI Stock Forecast

Evolv Technologies stock forecast is as follows: a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

IMBI Analyst Ratings

Buy

According to 2 Wall Street analysts, Evolv Technologies's rating consensus is 'Buy'. The analyst rating breakdown for IMBI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
May 25, 2022	Craig-Hallum	Buy	Buy	Hold
May 25, 2022	B. Riley Securities	Buy	Buy	Hold
May 17, 2022	Craig-Hallum	Strong Buy	Strong Buy	Hold

Evolv Technologies's last stock rating was published by Craig-Hallum on May 25, 2022. The company gave IMBI a "Buy" rating, the same as its previous rate.

Evolv Technologies Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
FPAY	FlexShopper	$1.65	$2.50	51.52%	Buy
MNPR	Monopar Therapeutics	$22.05	$29.50	33.79%	Buy

IMBI Forecast FAQ

Is Evolv Technologies a good buy?

Yes, according to 2 Wall Street analysts, Evolv Technologies (IMBI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of IMBI's total ratings.